# DOT HeartMate 3 Study

> **NCT04974684** · NA · COMPLETED · sponsor: **Institute for Clinical and Experimental Medicine** · enrollment: 45 (actual)

## Conditions studied

- LVAD (Left Ventricular Assist Device) Thrombosis

## Interventions

- **DEVICE:** HeartMate 3
- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT04974684
- **Lead sponsor:** Institute for Clinical and Experimental Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04974684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04974684, "DOT HeartMate 3 Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04974684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*